Sex difference in response to non-small cell lung cancer immunotherapy: an updated meta-analysis

BACKGROUND: Studying sex differences in the efficacy of immunotherapy may contribute to the practice of the precision medicine, especially in non-small cell lung cancer (NSCLC), a kind of cancer with sexual bimorphism. METHODS: Published randomized controlled trials (RCTs), published by PubMed, Medl...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Jiali, Hong, Jiaze, Tang, Xin, Qiu, Xinyi, Zhu, Keying, Zhou, Liyuan, Guo, Dina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518269/
https://www.ncbi.nlm.nih.gov/pubmed/36128737
http://dx.doi.org/10.1080/07853890.2022.2124449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9518269/
https://www.ncbi.nlm.nih.gov/pubmed/36128737
http://dx.doi.org/10.1080/07853890.2022.2124449

Ejemplares similares